J'ai récemment eu le plaisir de faire appel aux services de cette entreprise et je dois dire que j'ai été très impressionné par le niveau de professionnalisme et d'expertise démontré tout au long du processus. L'équipe était incroyablement compétente et serviable, me guidant à chaque étape avec patience et soin. Le site Web était convivial et m’a fourni toutes les informations dont j’avais besoin pour prendre des décisions éclairées. L'attention portée aux détails et l'engagement envers la satisfaction du client étaient évidents dans chaque interaction que j'ai eue avec l'entreprise. Dans l'ensemble, je suis extrêmement satisfait du service exceptionnel que j'ai reçu et je recommande vivement cette entreprise à toute personne ayant besoin de ses services.
Ask AI about Assertio
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
AI-generated from reviews on this page. Verify anything important with the company directly.
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About Assertio
Assertio is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. The company was founded in 1995 and has established itself by developing and incorporating promising technology into differentiated therapeutic products, taking those products through clinical approval, and building a strong market presence. The company currently markets four FDA-approved products, Gralise® (gabapentin) tablets for the management of Postherpetic Neuralgia (PHN), Cambia® (diclofenac potassium for oral solution) for acute treatment of migraine attacks with or without aura in adults 18 years of age or older, Zipsor® (diclofenac potassium) liquid filled capsules for relief of mild to moderate acute pain, and Lazanda® (fentanyl) nasal spray CII for the management of breakthrough pain in cancer patients. See Important Safety Information for Gralise, Cambia, Zipsor, and Lazanda.
- Website
- assertiotx.com
- Phone
- 6504625900
- [email protected]
- Address
- 100 south saunders road
- Categories
- Pharmaceuticals
